IN2014DN03373A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN03373A IN2014DN03373A IN3373DEN2014A IN2014DN03373A IN 2014DN03373 A IN2014DN03373 A IN 2014DN03373A IN 3373DEN2014 A IN3373DEN2014 A IN 3373DEN2014A IN 2014DN03373 A IN2014DN03373 A IN 2014DN03373A
- Authority
- IN
- India
- Prior art keywords
- compositions
- water soluble
- sulphate
- salt
- sodium
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 5
- 239000008141 laxative Substances 0.000 abstract 4
- 230000001543 purgative effect Effects 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 2
- BPKUDUSVDVLOPY-UHFFFAOYSA-N bisoxatin Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C(=O)NC2=CC=CC=C2O1 BPKUDUSVDVLOPY-UHFFFAOYSA-N 0.000 abstract 2
- 229960002875 bisoxatin Drugs 0.000 abstract 2
- 235000000346 sugar Nutrition 0.000 abstract 2
- 239000004902 Softening Agent Substances 0.000 abstract 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract 1
- 235000019341 magnesium sulphate Nutrition 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 abstract 1
- 229910052939 potassium sulfate Inorganic materials 0.000 abstract 1
- 239000001120 potassium sulphate Substances 0.000 abstract 1
- 235000011151 potassium sulphates Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- GOZDTZWAMGHLDY-UHFFFAOYSA-L sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention provides compositions for use in purgatives for use as purgatives and to methods for inducing purgation of the colon. In alternative embodiments the invention provides compositions e.g. a purgative comprising: a water soluble sodium salt (especially sodium sulphate) a water soluble potassium salt (especially potassium sulphate) and a water soluble magnesium salt (especially magnesium sulphate); and compositions further comprising: a bisoxatin or a detergent stool softening agent (such as sodium picosulphate) and/or a water soluble sugar (such as xylose or equivalent); or compositions having these ingredients at different amounts but at equivalent proportions. In alternative embodiments the invention provides purgative compositions comprising electrolytes salts sugars bisoxatin dyes and biofilm disruptors.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552431P | 2011-10-27 | 2011-10-27 | |
| US201261717599P | 2012-10-23 | 2012-10-23 | |
| PCT/AU2012/001315 WO2013059881A1 (en) | 2011-10-27 | 2012-10-27 | Electrolyte purgatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN03373A true IN2014DN03373A (en) | 2015-06-05 |
Family
ID=48166953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3373DEN2014 IN2014DN03373A (en) | 2011-10-27 | 2012-10-27 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20150056140A1 (en) |
| EP (1) | EP2782581A4 (en) |
| JP (2) | JP6240610B2 (en) |
| KR (1) | KR20140090217A (en) |
| CN (1) | CN104010642B (en) |
| AU (2) | AU2012327212B2 (en) |
| BR (1) | BR112014009946A2 (en) |
| CA (1) | CA2853520C (en) |
| IL (1) | IL232218B (en) |
| IN (1) | IN2014DN03373A (en) |
| MX (1) | MX352891B (en) |
| PH (1) | PH12014500927B1 (en) |
| RU (1) | RU2640920C2 (en) |
| WO (1) | WO2013059881A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2651415B1 (en) | 2010-12-13 | 2020-10-07 | Rite-Prep Pty Ltd. | Gastric and colonic formulations and methods for making and using them |
| TWI535461B (en) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | Colon cleansing solution, composition for preparing the solution, kit comprising the composition or solution, and method of preparing the same |
| CN108175773A (en) | 2012-07-27 | 2018-06-19 | 红山生物医药有限公司 | For colon emptying preparation and prepare formulation method |
| DK3473248T3 (en) | 2012-09-11 | 2022-04-04 | Norgine Bv | COMPOSITIONS INCLUDING POLYETHYLENE GLYCOL AND ALKALIMETAL OR EARTHALIUM METAL SULPHATES FOR USE AS COLOR CLEANING COMPOSITIONS |
| CN105142617B (en) | 2013-03-15 | 2018-08-03 | 布伦特里实验室公司 | Dual purpose sulfate oral pharmaceutical composition tablet and method of use thereof |
| CN103585173B (en) * | 2013-10-28 | 2016-06-29 | 王显著 | Sulfur acid sodium and can the pharmaceutical composition of sulphuric acid |
| EP3191105A4 (en) * | 2014-09-12 | 2018-05-02 | Braintree Laboratories, Inc. | Sulfate salt solution laxative compositions and methods of use thereof |
| FR3049464B1 (en) * | 2016-03-29 | 2021-08-06 | Marc Girard | COLIC PREPARATIONS |
| US10143656B1 (en) | 2017-08-04 | 2018-12-04 | Braintree Laboratories, Inc. | Solid oral sulfate salt formulations for cleaning a colon and methods of using same |
| KR102127003B1 (en) * | 2017-10-12 | 2020-06-25 | 주식회사 한국팜비오 | Colonic purgative composition comprising sulfate salts |
| CN108244627A (en) * | 2018-01-16 | 2018-07-06 | 广西天昌投资有限公司 | A kind of banana oral liquid with ease constipation and preparation method thereof |
| KR102111094B1 (en) * | 2018-06-18 | 2020-05-14 | 주식회사 한국팜비오 | Oral solid formulation composition for purgative comprising sodium sulfate anhydrous, potassium sulfate, magnesium sulfate anhydrous and simethicone |
| WO2020006389A1 (en) * | 2018-06-29 | 2020-01-02 | Viktor Veniaminovich Tets | Compositions for modulating gut microbiota |
| RU2699222C1 (en) * | 2019-04-29 | 2019-09-04 | Алексей Владимирович Воронов | Electrolyte salt solution for enteral infusion |
| RU2709495C1 (en) * | 2019-08-01 | 2019-12-18 | Общество с ограниченной ответственностью "Гелеспон" | Method for intestine cleaning and kit for its implementation |
| WO2021133017A1 (en) * | 2019-12-23 | 2021-07-01 | 주식회사 비보존 | Colonic purgative composition |
| KR20220033810A (en) * | 2020-09-10 | 2022-03-17 | 강윤식 | Bowel Cleansing Supplementary beverage |
| US12239659B2 (en) | 2023-06-15 | 2025-03-04 | Braintree Laboratories, Inc. | Methods of administering safe colon cleansing compositions |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6162464A (en) * | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
| JP2000060487A (en) * | 1998-08-27 | 2000-02-29 | Kao Corp | Constipation improver |
| EE04580B1 (en) * | 2001-06-29 | 2006-02-15 | Tartu �likool | Microorganism strain Lactobacillus fermentum ME-3 as an antimicrobial and antioxidant probiotic |
| US7101573B2 (en) * | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| JP4458761B2 (en) * | 2003-03-27 | 2010-04-28 | ロート製薬株式会社 | Axillary preparation |
| US7687075B2 (en) * | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
| GB0409104D0 (en) * | 2004-04-23 | 2004-05-26 | Norgine Europe Bv | Compressed pharmaceutical compositions |
| WO2008134071A1 (en) * | 2007-04-26 | 2008-11-06 | Theraquest Biosciences, Inc. | Multimodal abuse resistant extended release formulations |
| WO2007057924A1 (en) * | 2005-11-21 | 2007-05-24 | Panacea Biotec Ltd | Laxative composition on the basis of triphala |
| WO2008021394A2 (en) * | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
| JP2008115085A (en) * | 2006-11-01 | 2008-05-22 | Tendou Seiyaku Kk | Laxative |
| US20090155363A1 (en) * | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
| US20090258090A1 (en) * | 2008-04-11 | 2009-10-15 | Braintree Laboratories, Inc. | Colon cleansing solution |
| WO2011047178A1 (en) * | 2009-10-14 | 2011-04-21 | Gi Innovation, Pllc | Colon cleansing of residual stool and secretions during colonoscopy |
| JP2011135936A (en) * | 2009-12-25 | 2011-07-14 | Toshiba Corp | Image processor, medical image diagnostic apparatus, and image processing program |
| EP2651415B1 (en) * | 2010-12-13 | 2020-10-07 | Rite-Prep Pty Ltd. | Gastric and colonic formulations and methods for making and using them |
| EP2667900B1 (en) * | 2011-01-28 | 2020-02-12 | William A. Shaver | Method, composition and package for bowel cleansing |
-
2012
- 2012-10-27 KR KR1020147013786A patent/KR20140090217A/en not_active Ceased
- 2012-10-27 JP JP2014537428A patent/JP6240610B2/en not_active Expired - Fee Related
- 2012-10-27 IN IN3373DEN2014 patent/IN2014DN03373A/en unknown
- 2012-10-27 CN CN201280058877.5A patent/CN104010642B/en not_active Expired - Fee Related
- 2012-10-27 US US14/353,744 patent/US20150056140A1/en not_active Abandoned
- 2012-10-27 WO PCT/AU2012/001315 patent/WO2013059881A1/en not_active Ceased
- 2012-10-27 MX MX2014004962A patent/MX352891B/en active IP Right Grant
- 2012-10-27 BR BR112014009946A patent/BR112014009946A2/en active Search and Examination
- 2012-10-27 PH PH1/2014/500927A patent/PH12014500927B1/en unknown
- 2012-10-27 RU RU2014121255A patent/RU2640920C2/en not_active IP Right Cessation
- 2012-10-27 AU AU2012327212A patent/AU2012327212B2/en active Active
- 2012-10-27 EP EP12844538.4A patent/EP2782581A4/en not_active Withdrawn
- 2012-10-27 CA CA2853520A patent/CA2853520C/en active Active
-
2014
- 2014-04-24 IL IL232218A patent/IL232218B/en active IP Right Grant
-
2016
- 2016-08-12 AU AU2016213892A patent/AU2016213892B2/en active Active
-
2017
- 2017-08-08 JP JP2017153176A patent/JP2018008997A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ723576A (en) | 2018-07-27 |
| CN104010642B (en) | 2018-08-17 |
| CA2853520C (en) | 2021-11-16 |
| EP2782581A4 (en) | 2015-05-20 |
| AU2012327212A1 (en) | 2013-05-23 |
| BR112014009946A2 (en) | 2017-04-25 |
| RU2014121255A (en) | 2015-12-10 |
| JP6240610B2 (en) | 2017-11-29 |
| WO2013059881A1 (en) | 2013-05-02 |
| IL232218A0 (en) | 2014-06-30 |
| KR20140090217A (en) | 2014-07-16 |
| CA2853520A1 (en) | 2013-05-02 |
| AU2012327212B2 (en) | 2016-05-12 |
| CN104010642A (en) | 2014-08-27 |
| AU2016213892A1 (en) | 2016-09-01 |
| AU2016213892B2 (en) | 2018-04-05 |
| NZ624088A (en) | 2016-09-30 |
| PH12014500927A1 (en) | 2014-06-16 |
| RU2640920C2 (en) | 2018-01-12 |
| MX2014004962A (en) | 2015-01-16 |
| EP2782581A1 (en) | 2014-10-01 |
| MX352891B (en) | 2017-12-13 |
| US20150056140A1 (en) | 2015-02-26 |
| IL232218B (en) | 2018-10-31 |
| JP2015510491A (en) | 2015-04-09 |
| JP2018008997A (en) | 2018-01-18 |
| PH12014500927B1 (en) | 2017-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN03373A (en) | ||
| CN102660749B (en) | Phosphate-free degreasing agent | |
| AR087845A1 (en) | STABLE SOLUBLE ITEMS IN UNITARY DOSE WATER | |
| NZ743984A (en) | Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions | |
| BR112012022775A2 (en) | colon cleansing compositions and methods for producing and using them | |
| BR112012017062A2 (en) | "Detergent compositions containing geobacillus stearothermophilus lipase and methods for their use" | |
| MX393973B (en) | PROTEIN-ACTIVE AGENT CONJUGATES AND METHOD FOR THEIR PREPARATION. | |
| MX341464B (en) | Stabilization of fsh. | |
| PH12013502549B1 (en) | Fused benzoxazepinones as ion channel modulators | |
| MX2014003279A (en) | Detergent compositions comprising specific blend ratios of isoprenoid-based surfactants. | |
| MX2009008279A (en) | Fast dissolving solid detergent. | |
| NZ595785A (en) | Improvements in and relating to colon cleansing compositions | |
| WO2013043855A3 (en) | High suds detergent compositions comprising isoprenoid-based surfactants | |
| GB2486127A (en) | Improved deicer composition | |
| AR064483A1 (en) | COMPOSITION FOR WASHING DISHWASHER | |
| MX2011008153A (en) | Liquid hand dishwashing detergent composition. | |
| RU2013131274A (en) | LIQUID CLEANING COMPOSITIONS CONTAINING LONG CHAIN FAT ALCOHOLS | |
| WO2011007174A3 (en) | Composition and method | |
| RU2011152898A (en) | CHLORINATED ALKALINE DETERGENT METHANIC ACID PIPELINE | |
| RU2013156999A (en) | COMPOSITIONS FOR CARE FOR THE ORAL EMPLOYMENT CONTAINING PHYTIC ACID | |
| PL2643339T3 (en) | Novel hydrotropic agent, use thereof to make non-ionic surfactants soluble, and compositions containing same | |
| MY174609A (en) | Laundry detergent compositions including fermented fruit solutions | |
| EA201890638A1 (en) | DEVIATING ACIDS, CONTAINING WATER-RESISTANT REDUCTION ACTION, AND WAYS OF MANUFACTURE AND APPLICATION | |
| BR112012028524A2 (en) | pharmaceutical compositions, their uses and methods of preparation, water soluble solid composition and kits | |
| EA201171466A1 (en) | COMPOSITION OF UNTESERTAINABLE SALT, METHOD OF ITS RECEPTION AND USE |